Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study

Microbiological characterisation of co-infections and secondary infections in patients with COVID-19 is lacking, and antimicrobial use is high. The researchers aimed to describe microbiologically confirmed co-infections and secondary infections, and antimicrobial use, in patients admitted to hospital with COVID-19.

Original Source

Publication Date: 
02/06/2021
Clark D Russell, Cameron J Fairfield, Thomas M Drake & et al
Lancet Microbe
1-12
Tags:
Coronavirus, Infectious Diseases, Health Effects, Medical Research, United Kingdom (UK)